Dec. 19, 2019 Price forecast | 2 weeks: -2.88% | 1 month: -6.82% | 3 months: -5.49%


IART stock forecast

Our latest prediction for Integra LifeSciences Holdings Corp.'s stock price was made on the Dec. 19, 2019 when the stock price was at 59.39$.

In the short term (2weeks), IART's stock price should underperform the market by -2.88%. During that period the price should oscillate between -6.06% and +3.75%.

In the medium term (3months), IART's stock price should underperform the market by -5.49%. During that period the price should oscillate between -16.74% and +9.54%.

Create a solid portfolio with IART

Add IART to your portfolio and optimize it!


About Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

At the moment the company generates 1387M USD in revenues.

On its last earning announcement, the company reported a loss of -0.04$ per share.

The book value per share is 15.76$

Integra LifeSciences Holdings Corp. website


Three months stock forecastDec. 19, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1387M 61.70% 122M 8.80% -3M -0.04 - - 86M 15.76 207M -130M 78M